To view a list of CLSI documents helpful for COVID-19 testing click here.
To view a list of CLSI documents helpful for COVID-19 testing click here.

M52

Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, 1st Edition

This guideline includes recommendations for verification of commercial US Food and Drug Administration–cleared microbial identification and antimicrobial susceptibility testing systems by clinical laboratory professionals to fulfill regulatory or quality assurance requirements for the use of these systems for diagnostic testing.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of January 2020. The document’s next scheduled review is generally five years after the reaffirmation date.

Members: $54.00 → $153.00

Nonmembers: $180.00
Log in/sign up to see price and add to cart

Details

Chairholder: Linda M. Mann, PhD, D(ABMM) and Dee Shortridge, PhD

Date of Publication: August 25, 2015

Order Code PDF: M52Ed1E
ISBN Number: 1-56238-912-2

Order Code Print: M52Ed1
ISBN Number: 1-56238-911-4

Edition: First

Pages: 92